Asploro Journal of Biomedical and Clinical Case Reports

Asploro Journal of Biomedical and Clinical Case Reports

Hiroshi Bando^1,2*
1Tokushima University / Medical Research, Tokushima, Japan
²Integrative Medicine Japan (IMJ), Shikoku Island Division, Tokushima, Japan

Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ^{ORCID iD}
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 19 July 2021; Accepted date: 07 August 2021; Published date: 15 August 2021

Citation: Bando H. Current Data on Lower Prevalence and Age-Related Aggravation of COVID-19 in Japan. Asp Biomed Clin Case Rep. 2021 Aug 15;4(2):153-56.

Copyright © 2021 Bando H. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Keywords: COVID-19, The Ministry of Health, Labour and Welfare of Japan, Severe Acute Respiratory Syndrome Coronavirus 2, Japan, John Hopkins University

Abbreviations: MHLW: Labour and Welfare of Japan; SARS-CoV-2: Severe Acute Respiratory Syndrome Coronavirus 2

Abstract

Pandemic COVID-19 has been crucial problem worldwide, and authors have reported less prevalence and excess death in Japan. The Ministry of Health, Labour and Welfare of Japan presented COVID-report of July 2021 Edition. Among them, the number of people diagnosed with COVID-19 in Japan was 796,835 until July 1, 2021, which is equivalent to 0.6% of the total population. Aggravation rate of COVID-19 increases remarkably with aging. The result shows 1, 4, 10, 25, 47, 70< in 30s, 40s, 50s, 60, 70s, 80s< years old, respectively. In contrast, it shows 0.5, 0.2, 0.3 in <9, 10-19, 20-29 years, respectively.